This edition is for information and study purposes only as the CME credits have expired.

Adult Ambulatory Medicine Self-Assessment Program (AAM-SAP™) is the competitive advantage you’ve been looking for in your managed care practice. Highly effective care is the kind of care which patients, purchasers of healthcare (employers), and health plans want. So the best way for you to gain the competitive edge is to be an effective medical manager. AAM-SAP™ provides you with a single reference source for management of the most commonly seen diseases in adult ambulatory medicine.

Target Audience: Primary Care Physicians, Internists, Family Physicians, and Doctors of Osteopathy.

AAM-SAP™ works to objectively validate and enhance your clinical knowledge and problem-solving skills in adult ambulatory, primary care medicine. Its assessment component will challenge you to eliminate inefficiency and waste, selecting the diagnosis, treatment, and follow-up care that is based on the “best management plan.” AAM-SAP™’s educational component will help you to strengthen your knowledge in areas that are confidentially identified for you in the score report/feedback component.

AAM-SAP™ addresses the following aspects of adult ambulatory primary care:

• Screening
• Differential diagnosis
• Follow-up
• Co-morbidities, and

• Evaluation
• Management
• Etiology
• Cost effective treatments.

Some of the key disease areas covered in the AAM-SAP™ include:

• Asthma
• Cancer — Breast, Cervical, Colorectal, Colon, Lung, and Prostate Screening
• Chronic Obstructive Pulmonary Disease (COPD)
• Coronary Artery Disease
• Diabetes: Albuminuria, Chronic Kidney Disease, Nephropathy, and General Management
• Dyslipidemia: Metabolic Syndrome, Health Disparities, and Managed Care Pharmacy
• Gastroesophageal Reflux Disease (GERD)
• Health Disparities
• Heart Disease: Angina, Aortic Stenosis, Congestive Heart Failure, Mitral Valve Prolapse, Rhythm Abnormalities, and Systolic Murmur
• Hypertension: Co-morbidities, Obstructive Sleep Apnea, Renal Insufficiency, Treatment-Resistant, Screening, and Stroke.
• Infectious Disease: including Fungal (Onychomycosis) and Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections
• Renal Disease: Renal Insufficiency, End-Stage Renal Disease
• Respiratory: Cough and Pneumonia
• Sleep Apnea

The estimated time for completion of this activity is 50 hours.

This enduring materials activity was released in October 2009. The AMA PRA Category 1 Credits™ are no longer valid.

AAM-SAP™ was developed without commercial support.

Back to Medical Introduction